These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 26318054
1. 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation. Medapi B, Suryadevara P, Renuka J, Sridevi JP, Yogeeswari P, Sriram D. Eur J Med Chem; 2015 Oct 20; 103():1-16. PubMed ID: 26318054 [Abstract] [Full Text] [Related]
2. Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors. Jeankumar VU, Renuka J, Santosh P, Soni V, Sridevi JP, Suryadevara P, Yogeeswari P, Sriram D. Eur J Med Chem; 2013 Oct 20; 70():143-53. PubMed ID: 24148991 [Abstract] [Full Text] [Related]
3. An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition. Reddy KI, Srihari K, Renuka J, Sree KS, Chuppala A, Jeankumar VU, Sridevi JP, Babu KS, Yogeeswari P, Sriram D. Bioorg Med Chem; 2014 Dec 01; 22(23):6552-6563. PubMed ID: 25456076 [Abstract] [Full Text] [Related]
4. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis. Renuka J, Reddy KI, Srihari K, Jeankumar VU, Shravan M, Sridevi JP, Yogeeswari P, Babu KS, Sriram D. Bioorg Med Chem; 2014 Sep 01; 22(17):4924-34. PubMed ID: 25129171 [Abstract] [Full Text] [Related]
5. Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Jeankumar VU, Reshma RS, Janupally R, Saxena S, Sridevi JP, Medapi B, Kulkarni P, Yogeeswari P, Sriram D. Org Biomol Chem; 2015 Feb 28; 13(8):2423-31. PubMed ID: 25569565 [Abstract] [Full Text] [Related]
9. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase. Carta A, Bua A, Corona P, Piras S, Briguglio I, Molicotti P, Zanetti S, Laurini E, Aulic S, Fermeglia M, Pricl S. Eur J Med Chem; 2019 Jan 01; 161():399-415. PubMed ID: 30384044 [Abstract] [Full Text] [Related]